Next Post

Izotropic Targets the Modern Investor and Engages GRIT Capital

VANCOUVER, BC – TheNewswire – April 19, 2022 – Izotropic Corporation (“Izotropic” or the “Firm“) (CSE:IZO) (CNSX:IZO.CN) (OTC:IZOZF) (FSE:1R3), a firm commercializing a committed breast CT (computed tomography) imaging system, IzoView, for the additional accurate detection and diagnosis of breast cancers, announces that as element of its company profile awareness tactic […]